141 related articles for article (PubMed ID: 12814463)
21. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period.
van Adelsberg J; Philip G; Pedinoff AJ; Meltzer EO; Ratner PH; Menten J; Reiss TF;
Allergy; 2003 Dec; 58(12):1268-76. PubMed ID: 14616102
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
Berger WE; White MV;
Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
[TBL] [Abstract][Full Text] [Related]
24. Effect of desloratadine on patients with allergic rhinitis and exercise-induced bronchoconstriction: a placebo controlled study.
Manjra AI; Nel H; Maharaj B
J Asthma; 2009 Mar; 46(2):156-9. PubMed ID: 19253122
[TBL] [Abstract][Full Text] [Related]
25. Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients.
Reinartz SM; Overbeek SE; Kleinjan A; van Drunen CM; Braunstahl GJ; Hoogsteden HC; Fokkens WJ
Allergy; 2005 Oct; 60(10):1301-7. PubMed ID: 16134997
[TBL] [Abstract][Full Text] [Related]
26. Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
Lu S; Malice MP; Dass SB; Reiss TF
J Asthma; 2009 Nov; 46(9):878-83. PubMed ID: 19905912
[TBL] [Abstract][Full Text] [Related]
27. Petasol butenoate complex (Ze 339) relieves allergic rhinitis-induced nasal obstruction more effectively than desloratadine.
Dumitru AF; Shamji M; Wagenmann M; Hindersin S; Scheckenbach K; Greve J; Klenzner T; Hess L; Nebel S; Zimmermann C; Zahner C; Schmidt-Weber CB; Chaker AM
J Allergy Clin Immunol; 2011 Jun; 127(6):1515-21.e6. PubMed ID: 21489609
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
Raphael GD; Angello JT; Wu MM; Druce HM
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
[TBL] [Abstract][Full Text] [Related]
29. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
[TBL] [Abstract][Full Text] [Related]
30. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
[TBL] [Abstract][Full Text] [Related]
31. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428
[TBL] [Abstract][Full Text] [Related]
32. Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis.
Wilson AM; Haggart K; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2002 Oct; 32(10):1504-9. PubMed ID: 12372132
[TBL] [Abstract][Full Text] [Related]
33. [The effect of antianaphylaxis drugs on specific IgE and eosinophil in serum of patients with allergic rhinitis].
Liu X; Xing Z; Gao Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(8):337-9. PubMed ID: 16075981
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis.
Pinar E; Eryigit O; Oncel S; Calli C; Yilmaz O; Yuksel H
Auris Nasus Larynx; 2008 Mar; 35(1):61-6. PubMed ID: 17826020
[TBL] [Abstract][Full Text] [Related]
35. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis.
Lee DK; Gardiner M; Haggart K; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):650-3. PubMed ID: 15080821
[TBL] [Abstract][Full Text] [Related]
36. Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.
Demoly P; Dreyfus I; Dhivert-Donnadieu H; Mesbah K
Ann Allergy Asthma Immunol; 2009 Sep; 103(3):260-6. PubMed ID: 19788025
[TBL] [Abstract][Full Text] [Related]
37. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis.
Wilken JA; Kane RL; Ellis AK; Rafeiro E; Briscoe MP; Sullivan CL; Day JH
Ann Allergy Asthma Immunol; 2003 Oct; 91(4):375-85. PubMed ID: 14582817
[TBL] [Abstract][Full Text] [Related]
38. Desloratadine therapy for symptoms associated with perennial allergic rhinitis.
Kim K; Sussman G; Hébert J; Lumry W; Lutsky B; Gates D
Ann Allergy Asthma Immunol; 2006 Mar; 96(3):460-5. PubMed ID: 16597081
[TBL] [Abstract][Full Text] [Related]
39. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
Stokes JR; Romero FA; Allan RJ; Phillips PG; Hackman F; Misfeldt J; Casale TB
J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
[TBL] [Abstract][Full Text] [Related]
40. Nasal eosinophilia and serum soluble intercellular adhesion molecule 1 in patients with allergic rhinitis treated with montelukast alone or in combination with desloratadine or levocetirizine.
Ciebiada M; Barylski M; Gorska Ciebiada M
Am J Rhinol Allergy; 2013; 27(2):e58-62. PubMed ID: 23562192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
